Your browser doesn't support javascript.
loading
Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.
Phan, Duc Binh; Jourdain, Hugo; González-Quesada, Alicia; Zureik, Mahmoud; Rivera-Díaz, Raquel; Sahuquillo-Torralba, Antonio; Descalzo-Gallego, Miguel Angel; Lunt, Mark; Garcia-Doval, Ignacio; Sbidian, Emilie; Warren, R B; Yiu, Zenas Z N.
Afiliação
  • Phan DB; Centre for Dermatology Research, Northern Care Alliance NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester, UK.
  • Jourdain H; EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), Saint-Denis, France.
  • González-Quesada A; Department of Dermatology, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.
  • Zureik M; EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), Saint-Denis, France.
  • Rivera-Díaz R; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Sahuquillo-Torralba A; Department of Dermatology, Hospital Universitario y Politecnico La Fe, Valencia, Spain.
  • Descalzo-Gallego MA; , Research Unit, Fundacion Piel Sana AEDV, Madrid, Spain.
  • Lunt M; Versus Arthritis Epidemiology Unit, The University of Manchester, Manchester, UK.
  • Garcia-Doval I; , Research Unit, Fundacion Piel Sana AEDV, Madrid, Spain.
  • Sbidian E; Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
  • Warren RB; EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), Saint-Denis, France.
  • Yiu ZZN; EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France.
BMJ Open ; 13(7): e075197, 2023 07 14.
Article em En | MEDLINE | ID: mdl-37451726
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Dermatite / Medicamentos Biossimilares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Dermatite / Medicamentos Biossimilares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido